CVRx shares surge 11.6% on strong Q1 results

Zacks Investment Research·29 Jun 2026·Read original

2▲1 ▼0Impact / 5

Earnings Health Care Equipment & Supplies

Summary · why it matters

CVRx shares rallied 11.6% in the last trading session to close at $5.86, driven by higher-than-usual trading volume. The jump came after the medical device company reported first-quarter 2026 results that beat expectations, with a loss per share of 50 cents and revenue of $14.8 million, both surpassing Zacks Consensus Estimates. For the upcoming quarter, analysts expect a loss of 52 cents per share and revenue of $15.64 million, representing a 15.1% year-over-year increase. Despite the strong price move, the consensus EPS estimate for the next quarter has remained unchanged over the last 30 days, and the stock currently carries a Zacks Rank of 3, or Hold.

CVRx Inc ▲